Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2021 ASCO Annual Meeting

NEXT STORY
Press release Biocartis Group NV: Results of the Extraordinary Shareholders’ Meeting held on 4 June 2021
PREV STORY
Europe Microplate Reader Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Type, Application, and End User
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

INVENTIVA Announces a U.S. Phase II Investigator-Initiated Study with Lanifibranor on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes

author_avatar
NASDAQ Market News

Six COVID-19 Patients Treated with RedHill’s Opaganib Under Compassionate Use Show Objective Clinical Improvement

author_avatar
NASDAQ Market News

PDS Biotechnology Signs Cooperative Research and Development Agreement with National Cancer Institute to Perform a Phase 2 Clinical Study of PDS0101 in Combination with Other Immune-modulating Agents in Advanced HPV-related Cancers

author_avatar
NASDAQ Market News